匯豐證券:重申新世界發展(0017.HK)“買入”評級 目標價50.3港元
匯豐證券發表研究報告指,新世界發展(0017.HK)最近推出的大圍站上蓋住宅項目“柏傲莊”將對集團銷售帶來驚喜,從而提升盈利上升空間,預期整個項目的可售資源約340億港元,相等於公司市值約35%,維持目標價50.3港元,重申“買入”投資評級,新世界發展亦為其中一個推薦的地產股。
匯豐證券表示,公司於房地產發展及房地產投資方面,均具備清晰的發展計劃,能提供良好的盈利前景,未來5年,預期公司的香港租賃組合增加150%,而中國內地的租賃組合上升240%,料2021年盈利預測按年反彈40%至92億港元,維持每股資產淨值預測為86.7港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.